Request Free Sample ×
U.S Medical Devices Market Research Report — Global Forecast till 2035 Infographic

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

US Medical Devices Market

ID: MRFR/MED/17597-HCR
100 Pages
Satyendra Maurya
Last Updated: April 06, 2026

U.S. Medical Devices Market Research Report: Size, Share, Trend Analysis By Device Type Outlook (Drug Delivery System, Diagnostic Devices, Invasive Devices, Respiratory Therapeutic Devices, Electronic Medical Device, Others), By Applications Outlook (Cardiovascular Diseases, Diagnostic Imaging, Orthopedics, Oncology, Ophthalmology, General Surgery, Respiratory, Dental, Ear, Nose, and Throat (ENT), Neurology, Nephrology Urology, Others) and By End Users Outlook (Hospitals Clinics, Ambulatory Surgical Centers, Homecare Settings, Others) - Growth Outlook & Industry Forecast 2025 To 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

US Medical Devices Market Infographic
Purchase Options
Compare License
Summary Table of Contents Segmentation Download PDF
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
  2.   1.1 EXECUTIVE SUMMARY
  3.     1.1.1 Market Overview
  4.     1.1.2 Key Findings
  5.     1.1.3 Market Segmentation
  6.     1.1.4 Competitive Landscape
  7.     1.1.5 Challenges and Opportunities
  8.     1.1.6 Future Outlook
  9. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
  10.   2.1 MARKET INTRODUCTION
  11.     2.1.1 Definition
  12.     2.1.2 Scope of the study
  13.       2.1.2.1 Research Objective
  14.       2.1.2.2 Assumption
  15.       2.1.2.3 Limitations
  16.   2.2 RESEARCH METHODOLOGY
  17.     2.2.1 Overview
  18.     2.2.2 Data Mining
  19.     2.2.3 Secondary Research
  20.     2.2.4 Primary Research
  21.       2.2.4.1 Primary Interviews and Information Gathering Process
  22.       2.2.4.2 Breakdown of Primary Respondents
  23.     2.2.5 Forecasting Model
  24.     2.2.6 Market Size Estimation
  25.       2.2.6.1 Bottom-Up Approach
  26.       2.2.6.2 Top-Down Approach
  27.     2.2.7 Data Triangulation
  28.     2.2.8 Validation
  29. 3 SECTION III: QUALITATIVE ANALYSIS
  30.   3.1 MARKET DYNAMICS
  31.     3.1.1 Overview
  32.     3.1.2 Drivers
  33.     3.1.3 Restraints
  34.     3.1.4 Opportunities
  35.   3.2 MARKET FACTOR ANALYSIS
  36.     3.2.1 Value chain Analysis
  37.     3.2.2 Porter's Five Forces Analysis
  38.       3.2.2.1 Bargaining Power of Suppliers
  39.       3.2.2.2 Bargaining Power of Buyers
  40.       3.2.2.3 Threat of New Entrants
  41.       3.2.2.4 Threat of Substitutes
  42.       3.2.2.5 Intensity of Rivalry
  43.     3.2.3 COVID-19 Impact Analysis
  44.       3.2.3.1 Market Impact Analysis
  45.       3.2.3.2 Regional Impact
  46.       3.2.3.3 Opportunity and Threat Analysis
  47. 4 SECTION IV: QUANTITATIVE ANALYSIS
  48.   4.1 Chemicals and Materials, BY Device Type (USD Billion)
  49.     4.1.1 Diagnostic Devices
  50.     4.1.2 Therapeutic Devices
  51.     4.1.3 Monitoring Devices
  52.     4.1.4 Surgical Instruments
  53.     4.1.5 Implantable Devices
  54.   4.2 Chemicals and Materials, BY End Use (USD Billion)
  55.     4.2.1 Hospitals
  56.     4.2.2 Clinics
  57.     4.2.3 Home Healthcare
  58.     4.2.4 Research Laboratories
  59.     4.2.5 Diagnostic Centers
  60.   4.3 Chemicals and Materials, BY Application (USD Billion)
  61.     4.3.1 Cardiology
  62.     4.3.2 Orthopedics
  63.     4.3.3 Neurology
  64.     4.3.4 Ophthalmology
  65.     4.3.5 General Surgery
  66.   4.4 Chemicals and Materials, BY Distribution Channel (USD Billion)
  67.     4.4.1 Direct Sales
  68.     4.4.2 Distributors
  69.     4.4.3 Online Sales
  70.     4.4.4 Retail Pharmacies
  71. 5 SECTION V: COMPETITIVE ANALYSIS
  72.   5.1 Competitive Landscape
  73.     5.1.1 Overview
  74.     5.1.2 Competitive Analysis
  75.     5.1.3 Market share Analysis
  76.     5.1.4 Major Growth Strategy in the Chemicals and Materials
  77.     5.1.5 Competitive Benchmarking
  78.     5.1.6 Leading Players in Terms of Number of Developments in the Chemicals and Materials
  79.     5.1.7 Key developments and growth strategies
  80.       5.1.7.1 New Product Launch/Service Deployment
  81.       5.1.7.2 Merger & Acquisitions
  82.       5.1.7.3 Joint Ventures
  83.     5.1.8 Major Players Financial Matrix
  84.       5.1.8.1 Sales and Operating Income
  85.       5.1.8.2 Major Players R&D Expenditure. 2023
  86.   5.2 Company Profiles
  87.     5.2.1 Medtronic (US)
  88.       5.2.1.1 Financial Overview
  89.       5.2.1.2 Products Offered
  90.       5.2.1.3 Key Developments
  91.       5.2.1.4 SWOT Analysis
  92.       5.2.1.5 Key Strategies
  93.     5.2.2 Abbott Laboratories (US)
  94.       5.2.2.1 Financial Overview
  95.       5.2.2.2 Products Offered
  96.       5.2.2.3 Key Developments
  97.       5.2.2.4 SWOT Analysis
  98.       5.2.2.5 Key Strategies
  99.     5.2.3 Boston Scientific (US)
  100.       5.2.3.1 Financial Overview
  101.       5.2.3.2 Products Offered
  102.       5.2.3.3 Key Developments
  103.       5.2.3.4 SWOT Analysis
  104.       5.2.3.5 Key Strategies
  105.     5.2.4 Johnson & Johnson (US)
  106.       5.2.4.1 Financial Overview
  107.       5.2.4.2 Products Offered
  108.       5.2.4.3 Key Developments
  109.       5.2.4.4 SWOT Analysis
  110.       5.2.4.5 Key Strategies
  111.     5.2.5 Siemens Healthineers (DE)
  112.       5.2.5.1 Financial Overview
  113.       5.2.5.2 Products Offered
  114.       5.2.5.3 Key Developments
  115.       5.2.5.4 SWOT Analysis
  116.       5.2.5.5 Key Strategies
  117.     5.2.6 Philips (NL)
  118.       5.2.6.1 Financial Overview
  119.       5.2.6.2 Products Offered
  120.       5.2.6.3 Key Developments
  121.       5.2.6.4 SWOT Analysis
  122.       5.2.6.5 Key Strategies
  123.     5.2.7 B. Braun Melsungen AG (DE)
  124.       5.2.7.1 Financial Overview
  125.       5.2.7.2 Products Offered
  126.       5.2.7.3 Key Developments
  127.       5.2.7.4 SWOT Analysis
  128.       5.2.7.5 Key Strategies
  129.     5.2.8 Stryker Corporation (US)
  130.       5.2.8.1 Financial Overview
  131.       5.2.8.2 Products Offered
  132.       5.2.8.3 Key Developments
  133.       5.2.8.4 SWOT Analysis
  134.       5.2.8.5 Key Strategies
  135.     5.2.9 GE Healthcare (US)
  136.       5.2.9.1 Financial Overview
  137.       5.2.9.2 Products Offered
  138.       5.2.9.3 Key Developments
  139.       5.2.9.4 SWOT Analysis
  140.       5.2.9.5 Key Strategies
  141.     5.2.10 Thermo Fisher Scientific (US)
  142.       5.2.10.1 Financial Overview
  143.       5.2.10.2 Products Offered
  144.       5.2.10.3 Key Developments
  145.       5.2.10.4 SWOT Analysis
  146.       5.2.10.5 Key Strategies
  147.   5.3 Appendix
  148.     5.3.1 References
  149.     5.3.2 Related Reports
  150. 6 LIST OF FIGURES
  151.   6.1 MARKET SYNOPSIS
  152.   6.2 US MARKET ANALYSIS BY DEVICE TYPE
  153.   6.3 US MARKET ANALYSIS BY END USE
  154.   6.4 US MARKET ANALYSIS BY APPLICATION
  155.   6.5 US MARKET ANALYSIS BY DISTRIBUTION CHANNEL
  156.   6.6 KEY BUYING CRITERIA OF CHEMICALS AND MATERIALS
  157.   6.7 RESEARCH PROCESS OF MRFR
  158.   6.8 DRO ANALYSIS OF CHEMICALS AND MATERIALS
  159.   6.9 DRIVERS IMPACT ANALYSIS: CHEMICALS AND MATERIALS
  160.   6.10 RESTRAINTS IMPACT ANALYSIS: CHEMICALS AND MATERIALS
  161.   6.11 SUPPLY / VALUE CHAIN: CHEMICALS AND MATERIALS
  162.   6.12 CHEMICALS AND MATERIALS, BY DEVICE TYPE, 2024 (% SHARE)
  163.   6.13 CHEMICALS AND MATERIALS, BY DEVICE TYPE, 2024 TO 2035 (USD Billion)
  164.   6.14 CHEMICALS AND MATERIALS, BY END USE, 2024 (% SHARE)
  165.   6.15 CHEMICALS AND MATERIALS, BY END USE, 2024 TO 2035 (USD Billion)
  166.   6.16 CHEMICALS AND MATERIALS, BY APPLICATION, 2024 (% SHARE)
  167.   6.17 CHEMICALS AND MATERIALS, BY APPLICATION, 2024 TO 2035 (USD Billion)
  168.   6.18 CHEMICALS AND MATERIALS, BY DISTRIBUTION CHANNEL, 2024 (% SHARE)
  169.   6.19 CHEMICALS AND MATERIALS, BY DISTRIBUTION CHANNEL, 2024 TO 2035 (USD Billion)
  170.   6.20 BENCHMARKING OF MAJOR COMPETITORS
  171. 7 LIST OF TABLES
  172.   7.1 LIST OF ASSUMPTIONS
  173.     7.1.1
  174.   7.2 US MARKET SIZE ESTIMATES; FORECAST
  175.     7.2.1 BY DEVICE TYPE, 2025-2035 (USD Billion)
  176.     7.2.2 BY END USE, 2025-2035 (USD Billion)
  177.     7.2.3 BY APPLICATION, 2025-2035 (USD Billion)
  178.     7.2.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
  179.   7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  180.     7.3.1
  181.   7.4 ACQUISITION/PARTNERSHIP
  182.     7.4.1

US Chemicals and Materials Market Segmentation

Chemicals and Materials By Device Type (USD Billion, 2025-2035)

  • Diagnostic Devices
  • Therapeutic Devices
  • Monitoring Devices
  • Surgical Instruments
  • Implantable Devices

Chemicals and Materials By End Use (USD Billion, 2025-2035)

  • Hospitals
  • Clinics
  • Home Healthcare
  • Research Laboratories
  • Diagnostic Centers

Chemicals and Materials By Application (USD Billion, 2025-2035)

  • Cardiology
  • Orthopedics
  • Neurology
  • Ophthalmology
  • General Surgery

Chemicals and Materials By Distribution Channel (USD Billion, 2025-2035)

  • Direct Sales
  • Distributors
  • Online Sales
  • Retail Pharmacies

Related Reports

No regional reports available for this market.

No country-specific reports available for this market.

Customer Stories
Case Study Cover Image
Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization ✓ ✓ ✓
Direct Access to Analyst ✓ ✓ ✓
Deliverable Format ✓ ✓ ✓
Platform Access ✗ ✗ ✓
Discount on Next Purchase 10% 15% 15%
Printable Versions ✗ ✗ ✓